Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
Zongru Jiang(University of Science and Technology of China), Qingsong Liu(University of Science and Technology of China)
Cited by 35
Related Papers
Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies
|Signal Transduction and Targeted Therapy|2023|46